The Division of Urogynecology has many active research studies for pelvic floor disorders, including urinary incontinence, pelvic organ prolapse, and bowel incontinence.
The division is fortunate to be part of the the Pelvic Floor Disorders Network (PFDN) which includes seven research sites across the US, supported by the National Institute of Child Health and Human Development.
Beta-Agonist versus Botox A® Trial for Urgency Urinary Incontinence (BEST) Trial: Therapy for Urge Urinary Incontinence
The purpose of this study is to fill the evidence gap with direct-comparison data on patient-important efficacy and safety outcomes between an oral medication (Mirabegron or Vibegron) versus Botox A® in the treatment of Urgency Urinary Incontinence. 432 women across 5 sites in the United States will be asked to participate. Women will be followed for a 12-month period.
Copyright © 2023 Care New England Health System